This inventor holds 2 USPTO granted patents. Top assignee: The Industry & Academic Cooperation in Chungnam National University (Iac). Active years: 2020-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020-2026
Title: Innovations by Dong Woon Kim
Introduction
Dong Woon Kim is a notable inventor based in Sejong, South Korea. He has made significant contributions to the field of medical technology, particularly through his innovative patents. With a total of 2 patents, his work focuses on addressing critical health issues.
Latest Patents
Dong Woon Kim's latest patents include a composite ultrathin coating film with inhibitory activity against hyperinflammatory response and bacteria, as well as a pharmaceutical composition for the prevention or treatment of chronic pain comprising Evans blue. The composite ultra-thin coating film is designed to be applied to medical silicone-based polymers, exhibiting excellent antibacterial activity while inhibiting deformed cell proliferation. This innovation ensures that hypertrophic tissue is not formed and maintains a lack of cytotoxicity. The second patent, which involves Evans blue, targets the VNUT protein of dorsal root ganglia, effectively reducing chronic pain, such as neuropathic pain, without side effects.
Career Highlights
Dong Woon Kim is affiliated with the Industry & Academic Cooperation in Chungnam National University. His work in this institution has allowed him to collaborate with other professionals in the field, enhancing the impact of his inventions.
Collaborations
Some of his notable coworkers include Won Hyung Lee and Sung Yun Yang. Their collaborative efforts contribute to the advancement of research and innovation in medical technology.
Conclusion
Dong Woon Kim's contributions to medical technology through his innovative patents demonstrate his commitment to improving health outcomes. His work continues to influence the field and offers promising solutions for chronic pain and infection control.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
